With new regulatory expectations for 2026 well underway, compliance for method suitability and defensibility continue to shape clinical drug development. Staying ahead of these evolving expectations remains essential for audit and filing survivability. Gateway Analytical supports pharmaceutical and biotech teams through proactive Method Verification Gap Checks to ensure your data package stands up to a scientific deep-dive.
For complex formulations, a “technically compliant” compendial method may be deemed indefensible if method suitability isn’t properly established. We provide the technical rigor to evaluate:
Method 1 and 2 Verification Decision Points: Determining the most defensible analytical path for your specific matrix.
Complex Matrix Compatibility: Addressing the technical limitations of standard testing for non-standard modalities.
Technical Documentation: Preparing regulatory-ready records that justify your particulate control strategy.
Choose Gateway Analytical as your partner for expert technical support as you navigate the 2026 landscape, ensuring your subvisible data is defensible remains essential to protecting your filing timeline.
📞 (724) 443-1900 | ✉️ in**@***************al.com
